Works matching IS 00070920 AND DT 2013 AND VI 109 AND IP 1


Results: 47
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Tumour morphology predicts PALB2 germline mutation status.

    Published in:
    British Journal of Cancer, 2013, v. 109, n. 1, p. 154, doi. 10.1038/bjc.2013.295
    By:
    • Teo, Z L;
    • Provenzano, E;
    • Dite, G S;
    • Park, D J;
    • Apicella, C;
    • Sawyer, S D;
    • James, P A;
    • Mitchell, G;
    • Trainer, A H;
    • Lindeman, G J;
    • Shackleton, K;
    • Cicciarelli, L;
    • Buys, S S;
    • Andrulis, I L;
    • Mulligan, A M;
    • Glendon, G;
    • John, E M;
    • Terry, M B;
    • Daly, M;
    • Odefrey, F A
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.

    Published in:
    British Journal of Cancer, 2013, v. 109, n. 1, p. 121, doi. 10.1038/bjc.2013.272
    By:
    • Alcaraz, A;
    • González-López, R;
    • Morote, J;
    • de la Piedra, C;
    • Meseguer, C;
    • Esteban, E;
    • Climent, M;
    • González-Gragera, B;
    • Álvarez-Ossorio, J-L;
    • Chirivella, I;
    • Mellado, B;
    • Lara, P-C;
    • Vázquez, F;
    • Contreras, J-A;
    • Carles, J;
    • Murias, A;
    • Calderero, V;
    • Comet-Batlle, J;
    • González-del Alba, A;
    • León-Mateos, L
    Publication type:
    Article
    46
    47